We performed western blot assays to assess the expression levels of apoptosis- associated proteins (cleaved-caspase 3, Bax and Bcl-2) to further elucidate the molecular mechanisms by which CCN1 participates in NASH (Fig. 9). The gene discussed is CASP3; the disease is metabolic dysfunction-associated steatohepatitis.